Full Name
عبدالرحمن المناصير
Identification Number
9521012872
Telephone Number
00000000
Record Created
2026-07-27 08:58
History of Present Illness (HPI)
74Y M
K/C OF CHOLANGIOCARCINOMA WITH METS
REFERRED TO US DUE TO RECURRENT VISITS TO ER DUE TO
ABD PAIN
VOMITING
WEIGHT LOSS >20 KG IN LAST 4 MONTHS
SUSPICIOUS CHOLANGIOCARCINOMA WITH METS ON PET SCAN IN : LNS IN NECK, ABD, CHEST, LUNGS AND BONE.
Medical Conditions
1 record(s)
| Condition |
Type |
Diagnosis Date |
ICD-10 |
Severity |
Status |
Notes |
| COPD |
Chronic |
- |
J44.9 |
- |
In Remission |
- |
Family Medical History
0 record(s)
No family medical history was recorded.
Surgeries
4 record(s)
Findings
Anterograde cholangiogram shows severe left intrahepatic biliary dilation with occluded segment of left biliary duct.
8.5 FR internal-external biliary drain was inserted and functioning well.
Findings
Anterograde cholangiogram shows severe left intrahepatic biliary dilation with occluded segment of left biliary duct.
8 FR external biliary drain was inserted and functioning well.
Findings
SPECIFIC DATE AND FINDINGS UNKNOWN
Findings
SPECIFIC DATE AND FINDINGS UNKNOWN
Chemotherapy
0 record(s)
No chemotherapy records were recorded.
Radiology Records
3 record(s)
Clinical Indication
Staging
Clinical Indication
Suspected Cholangiocarcinoma
Impression
Hypermetabolic potentially malignant liver lesion, mostly originating from the biliary tree and highly suspicious cholangiocarcinoma, tissue confirmation is mandatory.
Hypermetabolic potentially metastatic process involving multiple lymph nodes groups within neck, chest and abd, both lungs and bone.
Impression
The constellation of findings are mostly consistent with cholangiocarcinoma with lung and bony metastases.
Specialist Opinions
1 record(s)
Opinion Note
Palliative chemotherapy
Recommendation
Palliative chemotherapy
Cisplatin
Gemzar
Laboratory Tests
4 record(s)
| Date |
Test |
Category |
Result |
Reference Range |
Status |
Notes |
| 2026-04-29 |
CA19-9 |
Tumor Markers |
21.59
U/ml
|
0-39 |
Normal |
- |
| 2026-04-29 |
CA 125 |
Tumor Markers |
131.5
U/ml
|
0-35 |
High |
- |
| 2026-04-29 |
CEA |
Tumor Markers |
55.43
Ng/ml
|
Up to 5.0 (smoker) |
High |
- |
| 2026-04-29 |
AFP |
Tumor Markers |
7.6
Ng/ml
|
Up to 10.0 (SMOKER) |
High |
- |